The non-small cell lung cancer therapeutics market comprises various treatment options for the most common type of lung cancer including targeted therapies, immunotherapy, and chemotherapy. Non-small cell lung cancer accounts for nearly 85% of all lung cancer cases and presents significant symptoms such as persistent coughing, shortness of breath, chest pain, and weight loss. https://logcla.com/blogs/542614/Non-Small-Cell-Lung-Cancer-Therapeutics-Advances-are-Driving-Market